Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Abeona Therapeutics (ABEO) over the last 12 years, with Q3 2025 value amounting to $129000.0.

  • Abeona Therapeutics' Non Operating Income fell 1103.45% to $129000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 3718.12%. This contributed to the annual value of $1.2 million for FY2024, which is 5942.92% down from last year.
  • Latest data reveals that Abeona Therapeutics reported Non Operating Income of $129000.0 as of Q3 2025, which was down 1103.45% from $89000.0 recorded in Q2 2025.
  • Over the past 5 years, Abeona Therapeutics' Non Operating Income peaked at $2.2 million during Q2 2023, and registered a low of -$118000.0 during Q2 2022.
  • Moreover, its 4-year median value for Non Operating Income was $153500.0 (2024), whereas its average is $331142.9.
  • In the last 5 years, Abeona Therapeutics' Non Operating Income skyrocketed by 197711.86% in 2023 and then tumbled by 8988.71% in 2024.
  • Abeona Therapeutics' Non Operating Income (Quarter) stood at $277000.0 in 2022, then dropped by 22.74% to $214000.0 in 2023, then surged by 209.81% to $663000.0 in 2024, then tumbled by 80.54% to $129000.0 in 2025.
  • Its last three reported values are $129000.0 in Q3 2025, $89000.0 for Q2 2025, and $141000.0 during Q1 2025.